Stay updated on AMV564 Study in AML Patients Clinical Trial
Sign up to get notified when there's something new on the AMV564 Study in AML Patients Clinical Trial page.

Latest updates to the AMV564 Study in AML Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record for the AMV564 AML trial is displayed with its study design, eligibility criteria, participating locations, and outcome measures. The prior access-denied message is no longer shown.SummaryDifference49%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check23 days agoChange DetectedA notice appears above the study record explaining that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the content while the site header and footer remain visible.SummaryDifference18%

Stay in the know with updates to AMV564 Study in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMV564 Study in AML Patients Clinical Trial page.